Circadian Rhythms in Exudative Age-Related Macular Degeneration: The Key Role of the Canonical WNT/β-Catenin Pathway

Int J Mol Sci. 2020 Jan 27;21(3):820. doi: 10.3390/ijms21030820.

Abstract

Age-related macular degeneration (AMD) is considered as the main worldwide cause of blindness in elderly adults. Exudative AMD type represents 10 to 15% of macular degeneration cases, but is the main cause of vision loss and blindness. Circadian rhythm changes are associated with aging and could further accelerate it. However, the link between circadian rhythms and exudative AMD is not fully understood. Some evidence suggests that dysregulation of circadian functions could be manifestations of diseases or could be risk factors for the development of disease in elderly adults. Biological rhythms are complex systems interacting with the environment and control several physiological pathways. Recent findings have shown that the dysregulation of circadian rhythms is correlated with exudative AMD. One of the main pathways involved in exudative AMD is the canonical WNT/β-catenin pathway. Circadian clocks have a main role in some tissues by driving the circadian expression of genes involved in physiological and metabolic functions. In exudative AMD, the increase of the canonical WNT/β-catenin pathway is enhanced by the dysregulation of circadian rhythms. Exudative AMD progression is associated with major metabolic reprogramming, initiated by aberrant WNT/β-catenin pathway, of aerobic glycolysis. This review focuses on the interest of circadian rhythm dysregulation in exudative AMD through the aberrant upregulation of the canonical WNT/β-catenin pathway.

Keywords: WNT/β-catenin pathway; Warburg effect; aerobic glycolysis; circadian rhythms; exudative AMD.

Publication types

  • Review

MeSH terms

  • Animals
  • Circadian Clocks / genetics
  • Circadian Rhythm*
  • Glucose / metabolism
  • Glycolysis
  • Humans
  • Macular Degeneration / etiology*
  • Macular Degeneration / metabolism*
  • Macular Degeneration / pathology
  • Neovascularization, Pathologic / metabolism
  • Wnt Signaling Pathway*

Substances

  • Glucose